SynthesisCurrent allergy and asthma reports2021

Efficacy and Safety of Prostaglandin D2 Receptor 2 Antagonism with Fevipiprant for Patients with Asthma: a Systematic Review and Meta-analysis of Randomized Controlled Trials.

Dan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.